Sébastien Bougnaud

773 total citations
12 papers, 398 citations indexed

About

Sébastien Bougnaud is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Sébastien Bougnaud has authored 12 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Immunology and 4 papers in Genetics. Recurrent topics in Sébastien Bougnaud's work include Pancreatic and Hepatic Oncology Research (6 papers), Phagocytosis and Immune Regulation (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Sébastien Bougnaud is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Phagocytosis and Immune Regulation (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Sébastien Bougnaud collaborates with scholars based in Norway, Luxembourg and France. Sébastien Bougnaud's co-authors include Simone P. Niclou, Rolf Bjerkvig, Anna Golebiewska, Nicolaas H. C. Brons, Daniel Stieber, Laurent Vallar, Frank Hertel, Uroš Rajčević, Anaïs Oudin and Thang V. Pham and has published in prestigious journals such as Journal of Clinical Oncology, Brain and Cancer Research.

In The Last Decade

Sébastien Bougnaud

12 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sébastien Bougnaud Norway 8 189 153 127 124 57 12 398
Uroš Rajčević Slovenia 11 281 1.5× 110 0.7× 121 1.0× 103 0.8× 57 1.0× 20 491
Callie G. Flack United States 4 200 1.1× 137 0.9× 173 1.4× 135 1.1× 35 0.6× 5 353
Jessica G. Crowley United States 5 210 1.1× 137 0.9× 175 1.4× 152 1.2× 35 0.6× 6 375
Cécile Henry France 10 205 1.1× 115 0.8× 98 0.8× 76 0.6× 63 1.1× 19 405
Aleksandra Olow United States 10 233 1.2× 104 0.7× 124 1.0× 55 0.4× 83 1.5× 18 458
Krissie Lenting Netherlands 7 228 1.2× 247 1.6× 60 0.5× 198 1.6× 43 0.8× 9 468
Henry Withers United States 8 177 0.9× 63 0.4× 114 0.9× 84 0.7× 85 1.5× 16 349
Lisa C. Wallace United States 4 301 1.6× 187 1.2× 115 0.9× 175 1.4× 53 0.9× 7 477
Parvinder Hothi United States 11 280 1.5× 149 1.0× 147 1.2× 152 1.2× 59 1.0× 14 508
Dorota Goplen Norway 12 251 1.3× 126 0.8× 106 0.8× 70 0.6× 46 0.8× 22 485

Countries citing papers authored by Sébastien Bougnaud

Since Specialization
Citations

This map shows the geographic impact of Sébastien Bougnaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sébastien Bougnaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sébastien Bougnaud more than expected).

Fields of papers citing papers by Sébastien Bougnaud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sébastien Bougnaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sébastien Bougnaud. The network helps show where Sébastien Bougnaud may publish in the future.

Co-authorship network of co-authors of Sébastien Bougnaud

This figure shows the co-authorship network connecting the top 25 collaborators of Sébastien Bougnaud. A scholar is included among the top collaborators of Sébastien Bougnaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sébastien Bougnaud. Sébastien Bougnaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Yule, Murray, Agnete S. T. Engelsen, Sébastien Bougnaud, et al.. (2018). Combination of bemcentinib (BGB324): A first-in-class selective oral AXL inhibitor, with pembrolizumab in patients with triple negative breast cancer and adenocarcinoma of the lung.. Journal of Clinical Oncology. 36(5_suppl). TPS43–TPS43. 13 indexed citations
2.
Du, Wenting, Agnete S. T. Engelsen, Stéphane Terry, et al.. (2018). Abstract 3774: BGB324, a selective small-molecule inhibitor of receptor tyrosine kinase AXL, targets tumor immune suppression and enhances immune checkpoint inhibitor efficacy. Cancer Research. 78(13_Supplement). 3774–3774. 4 indexed citations
3.
4.
Engelsen, Agnete S. T., Jing Kang, Sébastien Bougnaud, et al.. (2016). Abstract B027: BGB324, a selective small molecule inhibitor of AXL receptor tyrosine kinase, enhances immune checkpoint inhibitor efficacy. Cancer Immunology Research. 4(11_Supplement). B027–B027. 1 indexed citations
5.
Bougnaud, Sébastien, Anna Golebiewska, Anaïs Oudin, et al.. (2016). Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma. Oncotarget. 7(22). 31955–31971. 53 indexed citations
6.
Gausdal, Gro, Jing Kang, Agnete S. T. Engelsen, et al.. (2016). Abstract 566: BGB324, a selective small molecule inhibitor of the receptor tyrosine kinase AXL, enhances immune checkpoint inhibitor efficacy. Cancer Research. 76(14_Supplement). 566–566. 4 indexed citations
7.
Demeure, Kevin, Fred Fack, Elodie Duriez, et al.. (2015). Targeted Proteomics to Assess the Response to Anti-Angiogenic Treatment in Human Glioblastoma (GBM). Molecular & Cellular Proteomics. 15(2). 481–492. 22 indexed citations
8.
Rajčević, Uroš, Jaco C. Knol, Sander R. Piersma, et al.. (2014). Colorectal cancer derived organotypic spheroids maintain essential tissue characteristics but adapt their metabolism in culture. Proteome Science. 12(1). 39–39. 41 indexed citations
9.
Stieber, Daniel, Anna Golebiewska, Lisa Evers, et al.. (2013). Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes. Acta Neuropathologica. 127(2). 203–219. 81 indexed citations
10.
Golebiewska, Anna, Sébastien Bougnaud, Daniel Stieber, et al.. (2013). Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells. Brain. 136(5). 1462–1475. 69 indexed citations
11.
Goplen, Dorota, Sébastien Bougnaud, Uroš Rajčević, et al.. (2010). αB-Crystallin Is Elevated in Highly Infiltrative Apoptosis-Resistant Glioblastoma Cells. American Journal Of Pathology. 177(4). 1618–1628. 42 indexed citations
12.
Rajčević, Uroš, Kjell Petersen, Jaco C. Knol, et al.. (2009). iTRAQ-based Proteomics Profiling Reveals Increased Metabolic Activity and Cellular Cross-talk in Angiogenic Compared with Invasive Glioblastoma Phenotype. Molecular & Cellular Proteomics. 8(11). 2595–2612. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Uroš Rajčević Breakdown of academic impact, for papers by Callie G. Flack Breakdown of academic impact, for papers by Jessica G. Crowley Breakdown of academic impact, for papers by Cécile Henry Breakdown of academic impact, for papers by Aleksandra Olow Breakdown of academic impact, for papers by Krissie Lenting Breakdown of academic impact, for papers by Henry Withers Breakdown of academic impact, for papers by Lisa C. Wallace Breakdown of academic impact, for papers by Parvinder Hothi Breakdown of academic impact, for papers by Dorota Goplen
Rankless by CCL
2026